Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Return on Capital Employed (2022 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Return on Capital Employed for 4 consecutive years, with 0.37% as the latest value for Q1 2025.

  • On a quarterly basis, Return on Capital Employed changed N/A to 0.37% in Q1 2025 year-over-year; TTM through Mar 2025 was 0.37%, a N/A change, with the full-year FY2024 number at 0.49%, down 2.0% from a year prior.
  • Return on Capital Employed was 0.37% for Q1 2025 at Centessa Pharmaceuticals, up from 0.38% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.37% in Q1 2025 to a low of 0.52% in Q4 2023.
  • A 4-year average of 0.44% and a median of 0.44% in 2024 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: decreased -2bps in 2023, then increased 14bps in 2024.
  • Centessa Pharmaceuticals' Return on Capital Employed stood at 0.5% in 2022, then decreased by -4bps to 0.52% in 2023, then grew by 28bps to 0.38% in 2024, then grew by 1bps to 0.37% in 2025.
  • Per Business Quant, the three most recent readings for CNTA's Return on Capital Employed are 0.37% (Q1 2025), 0.38% (Q4 2024), and 0.52% (Q4 2023).